PUBLISHER: The Business Research Company | PRODUCT CODE: 1946725
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946725
Patient monitoring devices are tools used to continuously track and assess patients' health through various vital signs and alert systems. These devices allow healthcare providers to monitor key vital signs, such as heart rate, blood pressure, oxygen saturation, and respiratory rate, in real time. This continuous monitoring helps quickly detect any abnormalities, enabling prompt medical intervention and better patient care.
The primary categories within the patient monitoring devices market include fetal and neonatal monitoring devices, weight monitoring and body temperature monitoring devices and equipment, vital parameter monitoring devices and equipment, and remote patient monitoring devices and equipment. Fetal and neonatal monitoring devices, for instance, are used to measure the heart rate and rhythm of a baby (fetus), providing healthcare providers with important information about the baby's well-being. Expenditure in this field can be categorized as both public and private, and the products used include instruments/equipment and disposables. Patient monitoring devices are used by various end-users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
Tariffs are impacting the patient monitoring devices market by increasing costs of imported sensors, semiconductors, displays, communication modules, and electronic components used in vital sign and remote monitoring systems. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported medical electronics, while Asia-Pacific faces higher manufacturing and export-related costs. These tariffs are increasing equipment prices and delaying technology upgrades. However, they are also encouraging domestic manufacturing, regional electronics sourcing, and innovation in cost-efficient patient monitoring solutions.
The patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides patient monitoring devices market statistics, including patient monitoring devices industry global market size, regional shares, competitors with a patient monitoring devices market share, detailed patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the patient monitoring devices industry. This patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The patient monitoring devices market size has grown strongly in recent years. It will grow from $26.08 billion in 2025 to $28.03 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, expansion of intensive care units, growing use of electronic health records, increased demand for continuous patient observation.
The patient monitoring devices market size is expected to see strong growth in the next few years. It will grow to $38.2 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for home-based patient monitoring, rising investments in telehealth infrastructure, expansion of connected healthcare ecosystems, growing focus on preventive healthcare, increasing adoption of real-time analytics in patient care. Major trends in the forecast period include increasing adoption of remote patient monitoring solutions, rising use of wearable vital monitoring devices, expansion of continuous monitoring in critical care, growing integration of ai-based alert systems, enhanced focus on early diagnosis.
The rising prevalence of chronic diseases is expected to drive the growth of the patient monitoring device market. Chronic conditions are long-term health issues that typically cannot be cured but can be managed with proper care, and patient monitoring devices play a crucial role in managing these conditions. For example, in February 2024, the World Health Organization (WHO) projected that by 2050, the number of new cancer cases would exceed 35 million, a 77% increase from the estimated 20 million cases in 2022. As the prevalence of chronic diseases continues to rise, the demand for patient monitoring devices is expected to grow significantly.
Leading companies in the patient monitoring devices market are concentrating on developing innovative technologies, such as remote patient monitoring (RPM) hardware powered by LoRaWAN technology, to enhance their market profitability. LoRaWAN is a wireless communication protocol built upon the LoRa radio modulation technique. For instance, in January 2023, Senet, a US-based provider of cloud-based software and services platforms, and Telli Health, a US-based provider of medical remote patient monitoring devices, jointly introduced the first remote patient monitoring (RPM) hardware utilizing LoRaWAN technology. This technological advancement will enable healthcare providers to extend their services to a larger number of patients residing in remote and underserved areas, including indigenous communities worldwide. This development will enhance healthcare equity and inclusivity. The RPM device can be linked to a dedicated private LoRaWAN network, which can offer an approximate coverage range of 10 miles and requires only a simple dial-up modem for transmitting health readings.
In June 2024, Becton, Dickinson & Company (BD), a US-based provider of medical technology, devices, and laboratory instruments, acquired the Critical Care product group from Edwards Lifesciences for $4.2 billion. Through this acquisition, BD seeks to broaden its smart connected-care portfolio by incorporating advanced hemodynamic monitoring systems, AI-enabled clinical decision-support tools, and sensor technologies, thereby reinforcing its position in high-acuity patient monitoring. Edwards Lifesciences' Critical Care is a US-based company that provides patient monitoring devices.
Major companies operating in the patient monitoring devices market are General Electric Company, Koninklijke Philips NV, Dragerwerk AG & Co KGaA, Cardinal Health Inc., Masimo Corporation, Medtronic plc, Edwards Lifesciences Crop., Flex Ltd., Nihon Kohden Corporation, Abbott Laboratories, Johnson & Johnson, Siemens Healthineers AG, Becton Dickinson and Company, Cardinal Health Inc., Baxter International Inc., Boston Scientific Corporation, Danaher Corporation, 3M Company, Hill-Rom Holdings Inc., Terumo Corporation, Smith & Nephew plc, B. Braun Melsungen AG, ResMed Inc., Dexcom Inc., Fresenius Medical Care AG & Co. KGaA, Getinge, Mindray Medical International Limited, Nihon Kohden Corporation, Spacelabs Healthcare LLC, Nonin Medical Inc., OSI Systems Inc., Schiller AG, Welch Allyn Inc., OMRON Healthcare Co. Ltd.
Asia-Pacific was the largest region in the global patient monitoring devices market in 2025. North America was the second-largest region in the global patient monitoring devices market. The regions covered in the patient monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the patient monitoring devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The patient monitoring devices market consist of sales of instruments such as blood pressure cuffs, glucometers, pulse oximeter, ECG + stethoscope, wearables (activity trackers and continuous monitoring), and thermometers for patient monitoring. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Patient Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses patient monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for patient monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The patient monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.